GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioelife LITH · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Bioelife annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In USD.

FY2018FY2017FY2016FY2015FY2014
Operating income−$73,743−$125,059−$103,964−$61,352−$463,619
Net income−$336,958−$246,858−$209,513−$82,187−$498,326
Free cash flow−$76,691−$122,670−$133,849−$37,812−$41,228
Total assets$140,006$376,535$31,422$1,389$256
Shareholders' equity−$325,160−$70,612−$290,301−$217,806−$368,274

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.